2022
DOI: 10.1016/j.ymthe.2021.09.004
|View full text |Cite
|
Sign up to set email alerts
|

Far-red light-activated human islet-like designer cells enable sustained fine-tuned secretion of insulin for glucose control

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
13
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(19 citation statements)
references
References 62 publications
1
13
0
Order By: Relevance
“…More recently, a sophisticated approach to inducing neuronal cell death through light‐controlled transcription of a cytotoxic ion channel was implemented in zebrafish [69]. Light‐controlled transcription has also previously been used to induce insulin translation and expression in vivo by implanting engineered cells in mice [70]. Additionally, multiple optogenetic tools have been developed to control beta cell activity both in vitro and in vivo .…”
Section: Modulating Islet Function In Zebrafishmentioning
confidence: 99%
“…More recently, a sophisticated approach to inducing neuronal cell death through light‐controlled transcription of a cytotoxic ion channel was implemented in zebrafish [69]. Light‐controlled transcription has also previously been used to induce insulin translation and expression in vivo by implanting engineered cells in mice [70]. Additionally, multiple optogenetic tools have been developed to control beta cell activity both in vitro and in vivo .…”
Section: Modulating Islet Function In Zebrafishmentioning
confidence: 99%
“…An integrated system of monitoring and treatment is poised for clinical translation. FRL‐activated human islet‐like designer (FAID) cells have been developed for long‐term blood glucose control [84]. The FRL‐triggered optogenetic device was introduced into human mesenchymal stem cells, encapsulated in poly( L ‐lysine)‐alginate, and implanted subcutaneously under the dorsum of type 1 diabetic mice.…”
Section: Introductionmentioning
confidence: 99%
“…BphP1 was used in several OTs for the regulation of transcription ( Kaberniuk et al, 2016 ; Redchuk et al, 2017 , 2018b , 2018a ), intracellular protein targeting ( Redchuk et al, 2017 ; 2018b ; 2018a , 2020 ), and cell signaling control ( Kaberniuk et al, 2016 ; Redchuk et al, 2020 ). Non-invasive control of bacteriophytochome-based OTs was demonstrated in living mice ( Kaberniuk et al, 2016 ; Shao et al, 2017 ; Fomicheva et al, 2019 ; Wu et al, 2020 ; Wang et al, 2021 ; Yu et al, 2022 ). The functionality of light-induced BphP1-QPAS1 interaction was also shown in primary neurons ( Redchuk et al, 2018b ).…”
Section: Introductionmentioning
confidence: 99%